Koers Cerevel Therapeutics Holdings, Inc.
Aandelen
CERE
US15678U1280
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
42,12 USD | -0,06% | +0,57% | -0,73% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 7,65 mld. 7,18 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -456 mln. -428 mln. | Nettowinst (verlies) 2025 * | -551 mln. -517 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 709 mln. 666 mln. | Nettoliquiditeiten 2025 * | 690 mln. 648 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-16,9
x | K/w-verhouding 2025 * |
-15
x | Werknemers | 334 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 42,24% |
Recentste transcriptie over Cerevel Therapeutics Holdings, Inc.
1 dag | -0,06% | ||
1 week | +0,57% | ||
Lopende maand | -0,43% | ||
1 maand | -0,54% | ||
3 maanden | -0,38% | ||
6 maanden | +84,85% | ||
Lopend jaar | -0,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director of Finance/CFO | 43 | 15-05-23 | |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-06-19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01-09-18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04-12-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 42,1 | -0,11% | 301 695 |
18-04-24 | 42,14 | +1,30% | 1 282 830 |
17-04-24 | 41,6 | +0,70% | 838 023 |
16-04-24 | 41,31 | -0,94% | 1 439 526 |
15-04-24 | 41,7 | -0,36% | 1 333 538 |
uitgestelde koers Nasdaq, 19 april 2024 om 19:09 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,73% | 7,65 mld. | |
-2,83% | 102 mld. | |
+1,75% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,68% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,06% | 13,79 mld. | |
-0,23% | 13,33 mld. | |
+19,30% | 10,94 mld. |